Wall Street analysts forecast that MKS Instruments (MKSI) will report quarterly earnings of $1.92 per share in its upcoming release, pointing to a year-over-year increase of 64.1%. It is anticipated that revenues will amount to $910.58 million, exhibiting an increase of 2% compared to the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this ...

Wall Street analysts expect PPL (PPL) to post quarterly earnings of $0.37 per share in its upcoming report, which indicates a year-over-year decline of 7.5%. Revenues are expected to be $2.09 billion, up 3.1% from the year-ago quarter.Over the last 30 days, there has been an upward revision of 2.8% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Prior to ...

Wall Street analysts expect Copa Holdings (CPA) to post quarterly earnings of $3.84 per share in its upcoming report, which indicates a year-over-year decline of 14.1%. Revenues are expected to be $880.05 million, down 4% from the year-ago quarter.The current level reflects a downward revision of 3.5% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a co ...

Analysts on Wall Street project that Hyatt Hotels (H) will announce quarterly earnings of $0.65 per share in its forthcoming report, representing an increase of 1.6% year over year. Revenues are projected to reach $1.63 billion, declining 1.7% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period. ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

Though the outlook for 2025 remains broadly optimistic, the initial months of the year have quickly turned the U.S. stock market both tempestuous and uncertain.The release of DeepSeek – China’s novel artificial intelligence (AI) model – cast doubt upon the hundreds of billions already invested in big tech and the $500 billion planned for developing even stronger AI infrastructure.Subsequently, the news and rumors surrounding President Donald Trump’s tariffs, along with the differing international reactions ...

Pfizer’s (PFE)  fourth-quarter results were strong as it beat estimates for earnings as well as sales. Adjusted earnings per share of 63 cents were much higher than 10 cents in the year-ago quarter. Revenues came in at $17.76 billion, up 22% from the year-ago quarter.Higher sales of Pfizer’s key non-COVID products like Vyndaqel, Padcev and Eliquis and newly acquired products from Seagen, coupled with higher Paxlovid sales, drove the top line in the quarter. However, sales of some key drugs like Prevnar, Xel ...

BorgWarner (BWA) reported adjusted earnings of $1.01 per share for the fourth quarter of 2024, which surpassed the Zacks Consensus Estimate of 92 cents and increased from 90 cents recorded in the prior-year quarter. Better-than-expected bottom line from all segments apart from Drivetrain & Morse systems unit drove the outperformance.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The automotive equipment supplier reported net sales of $3.44 billion, which missed the Zacks Consensus Es ...

Quest Diagnostics (DGX) is gaining from advanced diagnostics offerings and strategic acquisitions. Rising debts and industry challenges continue to dent growth. The stock carries a Zacks Rank #3 (Hold).Factors Driving DGX StockQuest Diagnostics’ growth in the Physician Lab Services is backed by new customer wins, growing utilization of the company’s Advanced Diagnostics portfolio and contributions from acquisitions. The ongoing strength in healthcare utilization boosted growth throughout 2024. Quest Diagnos ...

Have you been paying attention to shares of Travel + Leisure Co. (TNL) ? Shares have been on the move with the stock up 12.8% over the past month. The stock hit a new 52-week high of $57.62 in the previous session. Travel + Leisure Co. has gained 11.7% since the start of the year compared to the 2.7% move for the Zacks Consumer Discretionary sector and the 5.4% return for the Zacks Leisure and Recreation Services industry.What's Driving the Outperformance?The stock has a great record of positive earnings su ...